{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": null, "type_of_material": "News", "word_count": "838", "lead_paragraph": "The maker of Contrave released early results from a clinical trial that suggested the drug was more beneficial than it actually is, according to the researchers who oversaw the study.", "pub_date": "2015-05-13T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Data Disclosure Leads Researchers to End Study of Obesity Drug"}, "snippet": "The maker of Contrave released early results from a clinical trial that suggested the drug was more beneficial than it actually is, according to the researchers who oversaw the study.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/05/13/business/data-disclosure-leads-researchers-to-end-study-of-obesity-drug.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Orexigen Therapeutics Inc", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Obesity", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Cleveland Clinic", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}], "blog": [], "_id": "5552b10938f0d86643ac571d", "source": "The New York Times"}